Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dystrophic hyperlucent lung (author's transl)].

F Berthoumieu, J Gaillard, G Fournal

    Le Poumon Et Le Coeur
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    From tuberculosis in general to renal tuberculosis.

    Toulouse medical·2010
    Same author

    In vivo participation of a high potential iron-sulfur protein as electron donor to the photochemical reaction center of Rubrivivax gelatinosus.

    Biochemistry·1995
    Same author

    Characterization of a mutated rubredoxin with a cysteine ligand of the iron replaced by serine.

    Biochemical and biophysical research communications·1995
    Same author

    Characterization of a 2[4Fe-4S] ferredoxin obtained by chemical insertion of the Fe-S clusters into the apoferredoxin II from Rhodobacter capsulatus.

    European journal of biochemistry·1995
    Same author

    Expression in Escherichia coli and characterization of a recombinant 7Fe ferredoxin of Rhodobacter capsulatus.

    The Biochemical journal·1992
    Same author

    Sequence-specific assignments of the 1H nuclear magnetic resonance spectra of reduced high-potential ferredoxin (HiPIP) from Chromatium vinosum.

    Biochemistry·1992
    Same journal

    [Secondarily infected pneumatocele, eosinophilia and excess production of IgE manifesting as Buckley's syndrome in an adult].

    Le Poumon et le coeur·1983
    Same journal

    [Bronchopulmonary pathology with hypereosinophilia of fungal origin (excluding allergic bronchopulmonary aspergillosis)].

    Le Poumon et le coeur·1983
    Same journal

    [Chronic eosinophilic pneumonia. Apropos of 2 cases].

    Le Poumon et le coeur·1983
    Same journal

    [Eosinophilic infiltrate with reference to Toxocara canis. Apropos of a case in an adult].

    Le Poumon et le coeur·1983
    Same journal

    [Pneumopathy caused by nitrofurantoin].

    Le Poumon et le coeur·1983
    Same journal

    [Clinical aspects and course of 38 cases of malignant pleural mesothelioma observed in the Marseilles region].

    Le Poumon et le coeur·1983
    See all related articles

    Surgical intervention for progressive dystrophic emphysema offers significant improvements. Early surgical intervention and creating pleural adhesions can limit disease progression in dystrophic hyperlucent lung conditions.

    Area of Science:

    • Pulmonology
    • Thoracic Surgery

    Context:

    • Dystrophic hyperlucent lung encompasses isolated emphysematous bullae and primitive progressive dystrophic emphysema.
    • Both conditions are considered surgical cases with varying prognoses.

    Purpose:

    • To analyze surgical indications and outcomes for progressive dystrophic emphysema.
    • To evaluate the effectiveness of surgical intervention in managing this condition.

    Summary:

    • The study reviewed 66 cases of progressive dystrophic emphysema, with 52 undergoing surgery.
    • Surgery demonstrated considerable improvements in patient outcomes.
    • Inducing pleural adhesion during surgery was found to limit the bullous evolution of the disease.

    Impact:

    Related Experiment Videos

  • Findings support early surgical intervention for progressive dystrophic emphysema.
  • Wider surgical indications are recommended to improve patient prognosis.
  • This research contributes to optimizing treatment strategies for dystrophic hyperlucent lung diseases.